Epstein-Barr virus infection after kidney transplantation

Transplant International

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Kaden, J ^a   Petersen, S ^a   Kaden, K ^a   May, G ^a  

^a VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

Author keywords

Epstein Barr virus; Infection; Kidney transplantation; Rejection

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD; EPSTEIN BARR VIRUS; FEMALE; HERPES VIRUS INFECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREVALENCE; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE;

EID: 0031608940     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1998.tb01094.x     Document Type: Article

References (22)

1. Cen H, Breinig MC, Atchison RW, Ho M, McKnight JL (1991) Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR 2, IR 3, and IR 4. J Virol 65: 976-980
2. Chatterjee SN, Chang RS (1982) A prospective study of oropharyngeal excretion of Epstein-Barr virus in renal kanograft recipients. Scand J Infect Dis 14: 95-98
3. Grose C, Henle W, Horwitz MS (1977) Epstein-Barr virus infection in a renal transplant recipient. South Med J 70: 1276-1278
4. Groth J, Schönemann C, Kaden J, May G (1996) Dynamics of donor-reactive IgG, IgA and IgM antibodies against T and B lymphocytes early after clinical kidney transplantation using flow cytometry. Transplant Immunol 4: 215-219
5. Harto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL (1985) Epstein-Barr virus immunodeficiency, and B cell lymphoproliferation. Transplantation 39: 461-472
6. Ho M (1995) Risk factors and pathogenesis of posttransplant lymphoproliferative disorders. Transplant Proc 27 (suppl 1): 38-40
7. Ho M, Miller G, Atchison R, Breinig MK, Dummer JS, Andiman W, Starzl TE, Eastmann R, Griffith BP, Hardesty L, Bahnson HT, Hakala R, Rosenthal JT (1985) Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 152: 876-886
8. Ho M, Jaffe R, Miller G, Breinig MK, Dummer JS, Makowa L, Atchinson RW, Karrer F, Nalesnik MA, Starzl TE (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45: 719-727
9. Kaden J, May G, Weßlau C, Müller P, Henkert M, Groth J (1992) Reduktion der OKT3-induzierten Zytokinfreisetzung in Abhängigkeit von der Prednisolondosis. Z Tx Med 4: 130-139
10. Kaden J, May G, Schönemann C, Müller P, Groth J, Seeger W, Seibt F, Henkert M, Lippert J (1992) Effect of ATG prophylaxis in sensitized and non-sensitized kidney graft recipients. Transpl Int 5 (suppl 1): 75-78
11. Kaden J, May G, Strobelt V, Groth J, Müller P (1997) Intraoperative T-cell depletion prior to completion of anastomo-ses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation. Transplant Proc 29: 344-347
12. Karajannis MA, Hummel M, Anagnostopoulos I, Stein H (1997) Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in non-immunocompromised individuals. Blood 89: 2856-2862
13. Marker SC, Ascher NL, Kalis JM, Simmons RL, Najarian JS, Balfour HH Jr (1979) Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery 85: 433-440
14. Nadal D, Guzmann J, Fröhlich S, Braun DG (1997) Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus associated lymphoproliferation. Exp Hematol 25: 223-231
15. Nalesnik M, Jaffe R, Starzl T, Demetris A, Porter K, Burnkam J, Makowka L, Ho M, Locker J (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133: 173-192
16. Prang NS, Hornef MW, Jäger M, Wagner HJ, Wolf H, Schwarzmann FM (1997) Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89: 1665-1677
17. Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrrell DLJ (1992) Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipient: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J Infect Dis 166: 986-994
18. Ren EC, Chan SH (1988) Possible enhancement of Epstein-Barr virus infections by the use of OKT3 in transplant recipients. Transplantation 45: 988-989
19. Rickinson AB, Moss DJ (1977) Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15: 405-531
20. Spencer ES, Andersen HK (1972) Antibodies to the Epstein-Barr virus in kidney transplant recipients. Acta Med Scand 191: 107-110
21. Straus SE, Cohen JI, Tosato G, Meier J (1993) Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 118: 45-58
22. Walker RC (1995) Pretransplant assessment of the risk for posttransplant lymphoproliferative disorder. Transplant Proc 27 (suppl 1): 41